Cargando…
Enhancing of Nanocatalyst-Driven Chemodynaminc Therapy for Endometrial Cancer Cells Through Inhibition of PINK1/Parkin-Mediated Mitophagy
PURPOSE: Iron-based nanomaterials have recently been developed as excellent and potent Fenton reagents to reactive oxygen species (ROS) during chemodynamic therapy (CDT). The performance of the materials, however, can be impaired by the intrinsic antioxidant defense mechanism in organisms, such as a...
Autores principales: | Gong, Xiaodi, Pu, Xin, Wang, Jing, Yang, Linlin, Cui, Yunxia, Li, Lijuan, Sun, Xiao, Liu, Jichang, Bai, Jingfeng, Wang, Yudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487866/ https://www.ncbi.nlm.nih.gov/pubmed/34616150 http://dx.doi.org/10.2147/IJN.S329341 |
Ejemplares similares
-
Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011) -
Loss of iron triggers PINK1/Parkin-independent mitophagy
por: Allen, George F G, et al.
Publicado: (2013) -
PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease
por: Li, Jie, et al.
Publicado: (2022) -
Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2017) -
The three ‘P’s of mitophagy: PARKIN, PINK1, and post-translational modifications
por: Durcan, Thomas M., et al.
Publicado: (2015)